SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,396 | -50.1% | 29,158 | +0.5% | 0.00% | – |
| Q2 2023 | $138,948 | -15.5% | 29,008 | 0.0% | 0.00% | – |
| Q1 2023 | $164,475 | +1.2% | 29,008 | 0.0% | 0.00% | – |
| Q4 2022 | $162,445 | -12.7% | 29,008 | 0.0% | 0.00% | – |
| Q3 2022 | $186,000 | +87.9% | 29,008 | 0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -51.9% | 29,008 | +0.0% | 0.00% | – |
| Q1 2022 | $206,000 | -14.9% | 28,998 | 0.0% | 0.00% | – |
| Q4 2021 | $242,000 | +19.8% | 28,998 | 0.0% | 0.00% | – |
| Q3 2021 | $202,000 | -70.8% | 28,998 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $692,000 | +42.1% | 28,998 | +22.5% | 0.00% | 0.0% |
| Q1 2021 | $487,000 | -37.3% | 23,675 | -25.3% | 0.00% | -50.0% |
| Q4 2020 | $777,000 | -15.5% | 31,705 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $919,000 | +496.8% | 32,455 | 0.0% | 0.00% | – |
| Q2 2020 | $154,000 | – | 32,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |